Lanxess Shares Face a Prolonged Period of Weakness

Lanxess reports a tough 2025, delays recovery to late 2026, and launches new cost cuts including job reductions and a salary freeze for management.

Investors in the specialty chemicals group Lanxess are being asked to brace for an extended wait. The company has concluded an exceptionally difficult 2025, with management tempering expectations for any rapid turnaround. CEO Matthias Zachert has indicated that a recovery is not anticipated before the second half of 2026 at the earliest, following a year of double-digit declines in both sales and profit.

Financial Performance and Strategic Moves

The group's operational performance reflected the severe challenges. Adjusted EBITDA fell by nearly 17 percent to 510 million euros for the past fiscal year. One positive development on the balance sheet was a 15 percent reduction in net financial debt to just over two billion euros, achieved through the divestment of the Urethane Systems business unit.

However, intense price competition from Asian rivals and persistently weak demand across nearly all industrial segments are forcing deeper strategic cuts. In response, Lanxess has launched a new cost-reduction initiative aimed at saving an additional 100 million euros annually by the end of 2028. This plan centers on the elimination of 550 positions, with two-thirds of the cuts affecting sites within Germany. Furthermore, the company has instituted a freeze on fixed salaries for its management and non-tariff staff.

Stock Price and Market Sentiment

The bleak outlook has left a profound mark on the company's market valuation. Lanxess shares recently touched a new 52-week low of 11.78 euros, having shed more than 40 percent of their value in the past month alone. From a technical analysis perspective, the stock appears oversold, with a Relative Strength Index (RSI) reading of 29.3. Yet, analysts note that a fundamental bottom in the share price has yet to be established.

Despite the ongoing crisis, the company's commitment to a stable dividend policy remains, albeit with a significant caveat. Future payouts will be strictly contingent on the prevailing economic conditions and the group's leverage ratio. All eyes are now on the annual general meeting scheduled for May 21, 2026. By that time, Lanxess must demonstrate that its extensive streamlining measures are sufficient to durably restore competitiveness against its Asian competitors.